Brought to you by 
Angel investors put €390k into Rhenovia Pharma
24 Feb 2014
Executive Summary
Rhenovia Pharma SAS (primarily CNS drug discovery) has raised €390k ($544k) in angel funding. Lead backer Alsace Business Angels' ABA Invest SAS contributed a total of €210k and was joined by Sodiv (€80k), which converted a previous loan into the equity stake, and two other executives. The company says it now has enough money to operate for the next two years.
Deal Industry
- Pharmaceuticals
- Services
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Angel investors put €390k into Rhenovia Pharma
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice